机译:BMS-986163,GLUN2B的负变性调节剂,具有主要抑郁症的潜在效用
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Biocon Bristol-Myers Squibb Research Center Bangalore India;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;
BMS-986163; BMS-986169; depression; GluN2B; ketamine; negative allosteric modulator; preclinical candidate;
机译:BMS-986163,GLUN2B的负变性调节剂,具有主要抑郁症的潜在效用
机译:代谢谷氨酸受体亚型5负抑郁症患者的人口药代动力学和暴露 - 头晕模拟
机译:Basimglurant用于治疗重度抑郁症:代谢型谷氨酸受体5的新型负变构调节剂
机译:教学机了解您的抑郁状态:健康和重度抑郁症中的体育活动
机译:烟碱型乙酰胆碱受体的负变构调节剂的治疗潜力
机译:BMS-986163GluN2B的负变构调节剂在严重抑郁症中的潜在效用
机译:代谢谷氨酸受体亚型5负抑郁症患者的人口药代动力学和暴露 - 头晕模拟